San Diego, CA, United States of America

Tracon Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 10

% Expired Patents = 60.0



Forward Citations = 71

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Charles P Theuer (10 out of 10 patents)

silverMedal Maximiliano Vasquez (5 out of 69 patents)

bronzeMedal Brian P Murphy (1 out of 135 patents)

4.  Mark Cornell Manning (1 out of 85 patents)

5.  Sharon Real (1 out of 1 patent)

6.  Bonne Jean Adams (1 out of 1 patent)

7.  Suzanne Pritchett Benedict (1 out of 5 patents)

8.  Ben K Seon (9 patents)

9.  Ben K Seon, (0 patent)


10 patents:

Company Overview
Tracon Pharmaceuticals, Inc. is a biopharmaceutical company based in San Diego, California, focused on the development of innovative therapies for cancer and other serious diseases. The company specializes in advancing targeted therapies that leverage its proprietary technology platforms, aiming to improve patient outcomes through precision medicine. Tracon is dedicated to addressing unmet medical needs by developing treatments that enhance the efficacy and safety of existing therapies, contributing to the evolving landscape of oncology and therapeutic development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

10 Patents

#534 in San Diego, CA

#7,121 in California

#29,892 in US

#56,119 in the World

San Diego, CA (US)
San Diego, CA, United States of America
Forward Citations = 71

7 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tracon Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/tracon-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…